Fleishman-Hillard to handle IR for BioStar Pharmaceuticals

XIANYANG, CHINA: BioStar Pharmaceuticals, a manufacturer of over-the-counter Hepatitis B medicine for the People's Republic of China, has tapped Fleishman-Hillard as its investor relations agency.

XIANYANG, CHINA: BioStar Pharmaceuticals, a manufacturer of over-the-counter Hepatitis B medicine for the People's Republic of China, has tapped Fleishman-Hillard as its investor relations agency.

Fleishman-Hillard will offer advisory services to BioStar for its investor communications and build relations programs to connect the company with global investors.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.